Investors are advised to refer through important disclosures made at the last page of the Research Report.

Size: px
Start display at page:

Download "Investors are advised to refer through important disclosures made at the last page of the Research Report."

Transcription

1 BSE SENSEX S&P CNX 24,470 7,425 Bloomberg SKSM IN Equity Shares (m) M.Cap. (INR b) / (USD b) 67.6/ Week Range (INR) 590 / 369 1, 6, 12 Rel. Per (%) 16/5/40 12M Avg Val (INR M) 863 Free float (%) 97.3 Financials & Valuation (INR Billion) Y/E March 2016E 2017E 2018E NII 5,774 7,629 10,445 PPP 4,440 5,912 8,071 PAT 3,103 4,329 5,786 EPS (INR) BV/Sh. (INR) RoA on AUM (%) RoE (%) Valuations P/E (x) P/BV (x) January QFY16 Results Update Sector: Financials SKS Microfinance CMP: INR535 TP: INR619 (16%) Buy Firing on all cylinders; scorching performance continues SKSM 3QFY16 PAT was up 94% YoY to INR795m (in line with est.), driven by strong operating performance. Stellar AUM growth of 93% YoY, stable asset quality, increase in average incremental ticket size to above INR15,000 improving operating leverage and marginal cost of funds at sub 10% were the key highlights for the quarter. AUM during the quarter grew at a scorching pace of 93% YoY and 13% QoQ, driven by customer additions and traction in long-term loans. Ticket size increase was also led by RBI s regulation allowing MFIs to lend higher amount to existing borrowers. Long-tenure loans (typically of two years) now constitute 32% of the total loan book v/s ~28% in the last quarter. Disbursements during the quarter were at INR29.8b (up 93% YoY and 12% QoQ). Marginal cost of borrowings (both on and off balance sheet) now stands at 10% v/s 11.9% in FY15 on the back of reduction in base rates by banks during the quarter, further helped by MUDRA loan of INR1b which SKS availed at 10% during the quarter. Strong PAT performance was driven by operating leverage as costs were kept under control evident from C/I ratio, which remained below 50% (at 47%) for the second consecutive quarter. Asset quality improved as absolute GNPA declined to INR63m v/s INR75m in the last quarter. %GNPA stood at 0.1% (stable YoY) and NNPA at 0.1%. Valuation and view: Large unmet demand, low competitive intensity, supportive regulations, strong balance sheet and best-in-class operating metrics have put SKSM on a high growth path. SKSM currently trades at 3.8x FY17E and 3.0x FY18E BV. While the valuations appear high, we believe they are justified given the high medium-term growth visibility, strong profitability and superior asset quality. Current valuations should sustain and could improve, given the strong profitability (42% PAT CAGR over FY15-18), healthy asset quality and capitalization. We increase our FY17/FY18 estimates marginally by 1.4%/2.6% to account for higher growth. Maintain Buy with a target price of INR619 (3.5x FY18E BV). Sunesh Khanna (Sunesh.Khanna@MotilalOswal.com); Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com) / Harshvardhan Agrawal (Harshvardhan.Agrawal@MotilalOswal.com) Investors are advised to refer through important disclosures made at the last page of the Research Report. Motilal Oswal research is available on Bloomberg, Thomson Reuters, Factset and S&P Capital.

2 Exhibit 1: Quarterly performance and reason for deviations Particulars 3QFY16E 3QFY16A v/s Est. Comments Net Income 2,068 2,107 2 Net income largely in-line Operating Expenses PPOP 1,080 1,118 4 Strong AUM growth led to higher PPoP Provisions Profit before Tax 980 1,031 5 Tax Provisions Tax rate 23% Net Profit Int Exp/ operating inc (%) Other Income / Total Income (%) Cost to Income Ratio (%) Tax Rate (%) AUM growth and fee income led to stellar performance AUM growing at stellar pace of 93% YoY AUM during the quarter grew at a scorching pace of 93% YoY and 13% QoQ was driven by customer additions as well as traction in long term loans. SKSM added 337,000 new active borrowers during the quarter which is a multi-year high. RBI during the quarter allowed MFIs to lend higher amount to existing borrowers, this helped the company to increase its average ticket size for exiting borrowers and the same spiked to INR15,692/borrower v/s INR13,405/borrower in the last quarter. Addition of new clients and increase in ticket size lead to strong growth in disbursement during the quarter at INR29.8b up 93% YoY and 12% QoQ. Long tenure loans (typical tenure of 2 years) now constitute 32% of the total loan book v/s ~28% in the last quarter (as ~65% of the fresh disbursement during the quarter were towards long term loan), however, income generating loan still continue to contribute over 41% of the total loan book (v/s ~43% in the last quarter). Cost of borrowing now at 10%; asset quality remains stable Marginal cost of borrowings (both on and off balance sheet) now stands at 10% v/s 11.9% in FY15. This is on back reduction in base rates by the most major banks following 50bps rate cut by the RBI towards the end of September. During the quarter, SKSM availed INR1b loan from MUDRA at 10% for onward lending. This also helped the company lower its borrowing costs. Strong PAT performance was also driven by operating leverage as costs were kept under control, evident from C/I ratio which remained below 50% at 47% for the second consecutive quarter. Asset quality continued to remain impeccable as %GNPA were at 0.1% (stable YoY and 0.2% last quarter) and NNPA at 0.1%. In absolute terms, GNPA declined to INR63m v/s INR75m in the last quarter. Other highlights: a) Market share gain continues for SKS with disbursement share standing at 19% in 2QFY15 and overall market share at 13%. b) MAT is now applicable on the company resulting in tax rate of 23%; un-availed DTA benefits stand at INR3.89b. c) RoE/RoA for 3QFY16 stands at 25.5%/4.5%; CAR at 23.9% with leverage of 3.6x. 28 January

3 Valuation and view The AP-crisis had resulted in a sharp decline in AUM and concurrent increase in GNPA for the MFI industry, leading to huge losses for the participants. However, timely RBI intervention led to stable and uniform regulations across the country. This de-risked the sector and provided a new lease of life to MFI companies, especially SKSM (SKSM had the largest AP portfolio at the time of crisis). The government has clarified that RBI would continue to be the sole regulator of the MFI sector and MUDRA, earlier envisaged as the regulator of MFIs, would now only provide refinancing. The regulatory clarity and continuity bodes well for the overall sector. SKSM has since witnessed an impressive turnaround, led by strong performance across operating parameters. The stock has also been re-rated in the last two years. We expect SKSM to continue to grow at a healthy pace, driven by vast geographic presence, experienced management and efficient operating metrics. We believe SKSM will be a prime beneficiary of underlying growth in the industry. With most of its peers busy turning themselves into SFBs, we expect 43% CAGR in SKSM s AUM over the next 2-3 years. SKSM would be the fastest growing company in our Financials coverage our 3-year PAT CAGR estimate for SKSM is 42%. Low competitive intensity, supportive regulations, strong balance sheet, and best-in class operating metrics have put SKSM on a high growth path. Currently, SKSM quotes at 3.8x FY17E and 3.0x FY18E BV. While these valuations appear high, we note that SKSM has traded at much higher multiples before the Andhra Pradesh crisis. We believe current valuations are justified, given high mediumterm growth visibility, strong profitability, and superior asset quality. Current valuations should sustain and could improve, given strong profitability (42% PAT CAGR over FY15-18), and healthy asset quality and capitalization. We marginally increase our FY17/FY18 estimates by 1.4%/2.6% to account for higher growth. Maintain Buy with target price of INR619 (3.5x FY18E BV). Exhibit 2: We marginally increase our estimates to account for higher AUM growth INR B Old Est Revised Est. % Change FY16 FY17 FY18 FY16 FY17 FY18 FY16 FY17 FY18 NII Other Income Net Income Operating Expenses Operating Profits Provisions PBT Tax PAT Loans Borrowings Spreads (%) RoAA (%) RoAE (%) January

4 Analysts meet highlights SKSM likely to grow at 70-80%: Potential in MFI industry still very large with unmet credit demand of INR1.5-3tn. SKSM hinted that growth is likely to remain at 70-80%; 50-60% coming from new client additions and 18-20% from increase in ticket size. SKSM intends to grow to faster pace primarily because it wants to acquire more clients before SFBs start operations. Further, threats from SHGs have largely subsided for SKSM as nearly 60% of SHGs are operational in AP and TN, areas where SKS has very minimal operations (some operations in AP and none in TN) Increased ticket size, raises concerns of over leveraging SKSM is taking utmost care in ensuring that MFI borrowers are not overleveraged and is strictly following the JLG principles and performing credit bureau checks. Further, as a prudent measure, it provides long term loans, which are loans above INR30,000 for upto two year tenure, only to customers who have completed two loan cycles with the company. With interest rates below 20%, political risks likely mitigated SKS reduced its interest rates to 19.75% in Dec-15. With this it has become the most efficient MFI in the world with sub 20% interest rate. The company is of the opinion that political risks associated with MFIs are largely mitigated by lending below 20%; as their exists many products such as personal loans by banks which charges more than 20% Operating efficiency to kick in with optimal utilization of existing infrastructure Operating leverage is likely to kick in FY17, as the company has now touched 4.2mn customers v/s 5.2mn before the crisis. It is only now that the company s existing infrastructure would be optimally utilized and thus cost efficiencies would kick in. Asset Quality to remain stable Asset quality likely to remain stable. The company being an NBFC is not required to make floating provisions, thus have not made any Cross sell to add 1% to RoA Increased focus on cross sell is likely to add 1% to RoA 28 January

5 Exhibit 3: Quarterly Snapshot FY14 FY15 FY16 Variation (%) 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 QoQ YoY Profit and Loss (INR m) Income from operations 1,028 1,143 1,148 1,169 1,272 1,658 1,635 1,767 2,173 2,664 2, Other operating income Total operating income 1,174 1,300 1,333 1,383 1,518 1,901 1,844 1,976 2,409 2,913 3, Other Income Total Income 1,226 1,352 1,397 1,474 1,690 2,010 2,069 2,262 2,826 3,243 3, Interest expenses ,008 1,169 1, Net income ,211 1,339 1,282 1,408 1,819 2,073 2, Total Opex Employees Depreciation and Amrt Others Operating profits ,099 1, Provisions and write offs Profit before tax ,012 1, Taxes NA Profit after tax Asset quality (Overall) Gross NPA Net NPA GNPA (%) NNPA (%) AUM related Overall AUM 23,450 23,480 23,640 28,370 27,830 30,430 31,950 41,710 47,970 54,620 61, On balance sheet 16,110 17,030 17,830 15,230 20,410 27,930 27,250 29,110 38,520 47,530 50, Other details CAR Branches 1,255 1,254 1,256 1,255 1,268 1,268 1,268 1,268 1,268 1,268 1,300 Centers (Sangam) 213, , , , , , , , , , ,214 Loan officers 6,429 5,647 5,350 5,259 5,124 5,094 5,104 5,286 5,656 6,066 6, January

6 Story in charts Exhibit 4: GLP grew at stellar 93% YoY SKS GLP (INR bn) YoY Growth (%) Exhibit 5: Client additions were also strong at 17% SKS Clients (mn) YoY Growth (%) QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 Exhibit 6: Ticket size spiked following RBI regulation Exhibit 7: Cost of borrowing declined to 11.3% 11,826 11,998 11,001 11,186 SKS Avg Tkt Size (INR) YoY Growth (%) 10,652 6 (4) (2) 14 (5) 12, , ,405 13,369 13, ,692 Cost of borrowing (%) 1QFY QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 Exhibit 8: Operating efficiency kicking in; C/I ratio at <50% Exhibit 9: Asset quality remains range bound Cost/Income Ratio (%) GNPA (%) NNPA (%) QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 28 January

7 Exhibit 10: Financials: Valuation Metrics 66 Rating CMP Mcap EPS (INR) P/E (x) BV (INR) P/BV (x) RoA (%) RoE (%) (INR) (USDb) FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 ICICIBC* Buy HDFCB Buy 1, AXSB Buy KMB* Neutral YES Buy IIB Buy DCBB Under Review FB Neutral JKBK Neutral SIB Buy Private Aggregate SBIN (cons)* Buy PNB Under Review BOI Neutral BOB Buy CBK Under Review UNBK Buy OBC Under Review INBK Buy CRPBK Neutral ANDB Buy IDBI Neutral DBNK Neutral Public Aggregate HDFC* Buy 1, LICHF Buy DEWH Buy IHFL Buy GRHF Buy REPCO Buy RECL Under Review POWF Under Review SHTF Buy MMFS Buy BAF Buy 5, ,582 1, MUTH Buy SKSM Buy NBFC Aggregate *Multiples adj. for value of key ventures/investments; For ICICI Bank and HDFC Ltd BV is adjusted for investments in subsidiaries 28 January

8 Financials and valuations INCOME STATEMENT (INR Million) Y/E MARCH E 2017E 2018E Interest Income on books Port. 3,589 2,200 3,930 5,665 9,587 12,983 16,860 Interest Expense 2,001 1,427 2,142 2,790 4,970 6,555 8,114 Net Financing income 1, ,788 2,874 4,617 6,429 8,746 Change (%) Income from assignment of loans ,158 1,200 1,700 Net Income (Incl Secur) 1,933 1,353 2,345 3,542 5,774 7,629 10,445 Change (%) Other operating income ,054 1,529 1,964 Other Income ,541 1,741 1,841 Net Income 2,722 2,098 3,306 5,240 8,369 10,899 14,250 Change (%) Operating Expenses 4,224 2,626 2,462 3,204 3,929 4,986 6,180 Change (%) Operating Profits -1, ,036 4,440 5,912 8,071 Change (%) Total Provisions 11,735 2, % to operating income PBT -13,237-2, ,936 4,030 5,479 7,324 Tax ,151 1,538 Tax Rate (%) PAT -13,606-2, ,877 3,103 4,329 5,786 Change (%) -1, Proposed Dividend ,157 BALANCE SHEET Y/E MARCH E 2017E 2018E Equity Share Capital 724 1,082 1,082 1,263 1,263 1,263 1,263 Reserves & Surplus 3,623 2,822 3,510 9,202 12,305 16,633 21,065 Networth 4,347 3,904 4,592 10,465 13,568 17,896 22,328 Borrowings 10,213 16,186 15,313 32,800 55,955 68,898 93,377 Change (%) Other liabilities 2,245 5,024 5,067 3,722 4,094 4,504 4,954 Change (%) Total Liabilities 16,805 25,115 24,972 46,987 73,617 91, ,659 Loans 9,496 15,654 17,528 29,584 49,800 63,386 85,907 Change (%) Investments Net Fixed Assets Other assets 7,101 9,346 7,330 17,299 23,724 27,827 34,675 Total Assets 16,805 25,115 24,972 46,987 73,617 91, , January

9 Financials and valuations RATIOS Y/E MARCH E 2017E 2018E Spreads Analysis (%) Avg. Yield - on Financing portfolio Avg. Cost of funds Interest Spread on Financing portfolio Net Interest Margin (incl Securitization) Net Interest Margin (Excl Securitization) Profitability Ratios (%) RoE RoA Op. Exps./Net Income Empl. Cost/Op. Exps Asset-Liability Profile (%) Net NPAs to Adv Debt/Equity (x) Average leverage CAR Valuations E 2017E 2018E Book Value (INR) Price-BV (x) EPS (INR) EPS Growth (%) -1, Price-Earnings (x) E: MOSL Estimates 28 January

10 Corporate profile Company description SKS Microfinance (SKSM) is the largest microfinance company in India in terms of gross loan portfolio. Its core business is providing small value loans and other basic financial services to its customers, who are predominantly located in rural areas. The company extends loans to them mainly for use in small businesses or for other income generating activities and not for personal consumption. As of 3QFY16, SKSM had an overall AUM of over INR60, with active customer base of 4.2m spread across 1,268 branches. Exhibit 11: Sensex rebased Exhibit 12: Shareholding pattern (%) Dec-15 Sep-15 Dec-14 Promoter DII FII Others Note: FII Includes depository receipts Exhibit 13: Top holders Holder Name % Holding IDFC Premier Equity Fund 5.3 Amansa Holdings Pvt Ltd 4.3 Sandstone Investment Partners I 4.1 Vinod Khosla 3.3 Tree Line Asia Master Fund (Singapore) Pte Ltd 3.0 Exhibit 14: Top management Name Designation Exhibit 15: Directors Name Name P H Ravi Kumar Chairman (Non-Executive) Sumir Chadha S Balachandran* M R Rao Managing Director & CEO Tarun Khanna* Punita Kumar Sinha* Paresh D Patel Geoffrey Tanner Woolley* P Krishnamurthy* *Independent Exhibit 16: Auditors Name S R Batliboi & Co LLP Type Statutory Exhibit 17: MOSL forecast v/s consensus EPS (INR) MOSL forecast Consensus forecast Variation (%) FY FY FY January

11 N O T E S 28 January

12 Disclosures SKS Microfinance This document has been prepared by Motilal Oswal Securities Limited (hereinafter referred to as Most) to provide information about the company(ies) and/sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the selected recipient/s and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a some companies covered by our Research Department. Our research professionals may provide input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may educate investors on investments in such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting information. Our research professionals are paid on the profitability of MOSt which may include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing among other things, may give rise to real or potential conflicts of interest. MOSt and its affiliated company(ies), their directors and employees and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the affiliates of MOSt even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report Reports based on technical and derivative analysis center on studying charts company's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamental analysis. In addition MOST has different business segments / Divisions with independent research separated by Chinese walls catering to different set of customers having various objectives, risk profiles, investment horizon, etc, and therefore may at times have different contrary views on stocks sectors and markets. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. Most and it s associates may have managed or co-managed public offering of securities, may have received compensation for investment banking or merchant banking or brokerage services, may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Most and it s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. Subject Company may have been a client of Most or its associates during twelve months preceding the date of distribution of the research report MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise of over 1 % at the end of the month immediately preceding the date of publication of the research in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Motilal Oswal Securities Limited is registered as a Research Analyst under SEBI (Research Analyst) Regulations, SEBI Reg. No. INH There are no material disciplinary action that been taken by any regulatory authority impacting equity research analysis activities Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues Disclosure of Interest Statement SKS Microfinance Analyst ownership of the stock No Served as an officer, director or employee No A graph of daily closing prices of securities is available at and Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Hong Kong: This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) SFO. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH ) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Kong Kong. This report is intended for distribution only to Professional Investors as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with professional investors. Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Kadambari Balachandran kadambari.balachandran@motilaloswal.com Contact : (+65) / Office Address : 21 (Suite 31),16 Collyer Quay,Singapore Motilal Oswal Securities Ltd 28 January 2016 Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai Phone: reports@motilaloswal.com

Repco Home Finance. CMP: INR637 TP: INR814 (+28%) Buy

Repco Home Finance. CMP: INR637 TP: INR814 (+28%) Buy BSE SENSEX S&P CNX 24,287 7,387 Bloomberg REPCO IN Equity Shares (m) 61.0 M.Cap. (INR b) / (USD b) 38.9/0.6 52-Week Range (INR) 785/570 1, 6, 12 Rel. Per (%) 1/-2/17 Avg Val (INR m) 73 Free float (%) 62.8

More information

JLR Nov-15 wholesale up 24% YoY to 51,021 units

JLR Nov-15 wholesale up 24% YoY to 51,021 units BSE Sensex S&P CNX 25,036 7,613 9 December 2015 Update Sector: Automobiles Tata Motors CMP: INR394 TP: INR471 (+20%) Buy Stock Info Bloomberg TTMT IN Equity Shares (m) 3,395.9 M.Cap. (INR b)/(usd b) 1,338/20

More information

MOSt Market Outlook 1st, July 2016

MOSt Market Outlook 1st, July 2016 Nifty Chart Nifty Outlook Nifty Fut. R1 R2 S1 S2 8326 8345 8380 8300 8160 'Nifty saw a strong recovery from the low of the weekly Spinning Top formation. For the ongoing momentum to sustain, follow up

More information

CMP: INR66 TP: INR40 (-39%) Sell

CMP: INR66 TP: INR40 (-39%) Sell BSE SENSEX S&P CNX 24,486 7,436 Bloomberg RCOM IN Equity Shares (m) 2,382.0 M.Cap.(INRb)/(USDb) 157.2 / 2.3 52-Week Range (INR) 92/46 1, 6, 12 Rel. Per (%) -19/11/-4 Avg Val, INR m 173.6 Free float (%)

More information

CMP: INR1199 TP: INR1474(+23%) Buy

CMP: INR1199 TP: INR1474(+23%) Buy 22 January 2016 Results Update Sector: Aviation InterGlobe Aviation BSE SENSEX S&P CNX 23,962 7,277 Bloomberg INDIGO IN Equity Shares (m) 360.4 M.Cap.(INRb)/(USDb) 431.5 / 6.3 52-Week Range (INR) 1,396/848

More information

Sep 2015: Strongest ever dispatch growth of 15% YoY

Sep 2015: Strongest ever dispatch growth of 15% YoY BSE Sensex S&P CNX 26,786 8,119 Stock Info Bloomberg COAL IN Equity Shares (m) 6,316.4 52-Week Range (INR) 7/301 1, 6, 12 Rel. Per (%) -11/-2/-5 M.Cap.(INR b)/(usd 2,084/31.9 b) AvgVal.INRm/Vol 000 1706/4532

More information

CMP: INR959 TP: INR1,380 (+44%)

CMP: INR959 TP: INR1,380 (+44%) BSE SENSEX S&P CNX 26,813 8,220 Stock Info Bloomberg ICNT IN Equity Shares (m) 39.5 52-Week Range (INR) 1,248/625 1, 6, 12 Rel. Per (%) 0/-13/57 M.Cap. (INR b)/ (USD b) 37.9/0.6 Avg Val ( INR m) 75 Free

More information

PAN mandatory for transactions above INR200,000

PAN mandatory for transactions above INR200,000 BSE Sensex S&P CNX 25,804 7,844 17 December 2015 Update Sector: Retail Titan Company CMP: INR354 TP: INR360 (+2%) Neutral PAN mandatory for transactions above INR200,000 Moderate impact on demand; near-term

More information

Khambatta Securities Ltd.

Khambatta Securities Ltd. Attractive Valuation Strong Buy Sector : Bank Private Target Price : Rs 284 Current Market Price : Rs 230 Market Cap : Rs 1,337 bn 52-week High/Low : Rs 393/216 Daily Avg. Volume : 13.88 mn Shares in issue

More information

HPCL CMP: INR288 TP: INR Buy

HPCL CMP: INR288 TP: INR Buy BSE SENSEX S&P CNX CMP: INR288 TP: INR Buy 17,831 5,412 Bloomberg HPCL IN Equity Shares (m) 339.0 52-Week Range (INR) 420/239 1,6,12 Rel. Perf. (%) 7/-31/-16 M.Cap. (INR b) 97.5 M.Cap. (USD b) 2.0 10 February

More information

Kotak Mahindra Bank Rs 685

Kotak Mahindra Bank Rs 685 India Equity Institutional Research BANKS RESULT UPDATE Kotak Mahindra Bank Rs 685 Smooth merger; benefits to accrue HOLD KMB s consolidated PAT for Q4FY15 stood at INR 9.5 that primarily on the back of

More information

Gujarat State Petronet Ltd. INR 135

Gujarat State Petronet Ltd. INR 135 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Oil & Gas RESULT UPDATE Gujarat State Petronet Ltd. INR 135 Growth in volumes to propel earnings Accumulate Gujarat

More information

Sandipan Pal (Sandipan.Pal@MotilalOswal.com); +91 22 3982 5436. 3QFY13 Results Update Sector: Real Estate Phoenix Mills CMP: INR257 TP: INR310 Buy

Sandipan Pal (Sandipan.Pal@MotilalOswal.com); +91 22 3982 5436. 3QFY13 Results Update Sector: Real Estate Phoenix Mills CMP: INR257 TP: INR310 Buy BSE Sensex S&P CNX 20,103 6,075 Bloomberg PHNX IN Equity Shares (m) 144.8 M.Cap. (INR b)/(usd b) 37.3/0.7 52-Week Range (INR) 274/155 1,6,12 Rel. Perf. (%) -3/27/30 Financials & Valuation (INR b) Y/E March

More information

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold HOLD Target price (INR) 452 Momentum in loans sustains, upgrade to Hold India Equity Research Financials January 30, 2013 Rating The higher than expected growth in the NII was driven by an improvement

More information

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16%

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16% India Equity Institutional Research BANKS RESULT UPDATE Axis Bank INR 521 Staunch operating metrics; but blemish asset quality ACCUMULATE With strong operating performance, Axis Bank reported net profit

More information

Strong operational performance

Strong operational performance ABB India Equity Research Engineering & Capital Goods February 8, 2016 Result Update Emkay Your success is our success Strong operational performance CMP Target Price Rs1,134 Rs1,407 ( ) Rating Upside

More information

Flexituff International Ltd. (FIL)

Flexituff International Ltd. (FIL) s $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 (Wholly owned subsidiary of Bank of Baroda) Q2FY16 Result Review BUY Flexituff International Ltd. (FIL)

More information

GAIL (India) Ltd. INR 346

GAIL (India) Ltd. INR 346 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Feb-16 India Equity Institutional Research Oil & Gas RESULT UPDATE GAIL (India) Ltd. INR 346 Good performance; Near term outlook looks stable BUY GAIL reported

More information

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research FY17 could be a year of revenue growth February 08, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating Accumulate Price Rs440 Target Price Rs510 Implied Upside 15.9% Sensex 24,617 Nifty

More information

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788

YES Bank HOLD. Not out of the woods yet; Asset quality remains a key monitorable. Institutional Equity Research. January 30, 2016. Target Price Rs788 January 3, 216 CMP* (Rs) 748 Upside/ (Downside) 5 Market Cap. (Rs bn) 314 Free Float 78 Shares O/S (mn) 419 YES Bank Not out of the woods yet; Asset quality remains a key monitorable YES Bank reported

More information

DLF CMP: INR211 TP: INR260 Buy

DLF CMP: INR211 TP: INR260 Buy BSE SENSEX S&P CNX 17,413 5,283 Bloomberg DLFU IN Equity Shares (m) 1,714.4 52-Week Range (INR) 261/170 1,6,12 Rel. Perf. (%) 1/-8/0 M.Cap. (INR b) 361.7 M.Cap. (USD b) 6.5 7 August 2012 1QFY13 Results

More information

Maruti Suzuki. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research Q3 results subdued, Outlook remains good; BUY January 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs4,103 Target Price Rs4,844 Implied Upside 18.1% Sensex 24,470 Nifty

More information

State Bank of India. Source: Company Data; PL Research

State Bank of India. Source: Company Data; PL Research Weak as expected; remain positive over medium term February 12, 2016 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating BUY Price Rs154 Target

More information

SKS Microfinance SELL. Need of the hour create floating provisions. Results Review INDIA TP: INR 345.00 30.7% SKSM IN

SKS Microfinance SELL. Need of the hour create floating provisions. Results Review INDIA TP: INR 345.00 30.7% SKSM IN 27 January 2016 SELL Need of the hour create floating provisions SKSM s Q3FY16 PAT grew 94% YoY to Rs 795mn, in line with RCMLe. Net interest income growth was strong at Rs 1.5bn but came in below RCMLe

More information

Britannia Industries

Britannia Industries Rally in Input costs near term drag, Maintain BUY June 20, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs2,641

More information

SKS Microfinance SELL. Need of the hour Create floating provisions. Results Review INDIA TP: INR 320.00 28.7% SKSM IN

SKS Microfinance SELL. Need of the hour Create floating provisions. Results Review INDIA TP: INR 320.00 28.7% SKSM IN 19 October 2015 SELL Need of the hour Create floating provisions SKSM s Q2FY16 PAT increased by 37% YoY to Rs 779mn, much higher than our estimates. Net interest income at Rs 1.5bn too was ahead of our

More information

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI.

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI. India Equity Institutional Research BFSI RESULT UPDATE ICICI BANK INR 233 Dismal asset quality performance BUY Q3FY15 earnings for ICICI Bank came as a huge disappointment with bank reporting highest NPAs

More information

Company Overview. Financial Performance

Company Overview. Financial Performance Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 SPS Finquest Ltd CMP: 84.60 January 13, 2015 Stock Details BSE code 538402 BSE ID SPS Face value ( ) 10 No of shares

More information

HCC BUY. Infrastructure January 29, 2016

HCC BUY. Infrastructure January 29, 2016 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 Dec-15 Jan-16 India Research Infrastructure January 29, 2016 QUARTERLY REVIEW Bloomberg: IN Reuters: HCNS.BO BUY Better margins drive earnings s

More information

Axis Bank. Strong core performance. Source: Company Data; PL Research

Axis Bank. Strong core performance. Source: Company Data; PL Research Strong core performance January 17, 2011 Abhijit Majumder abhijitmajumder@plindia.com +91 22 66322236 Umang Shah umangshah@plindia.com +91 22 66322242 Rating BUY Price Rs1,230 Target Price Rs1,600 Implied

More information

GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare Strong pricing power, Attractive valuations "BUY" February 09, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating BUY Price Rs5,837

More information

Minda Industries Ltd. INR 886

Minda Industries Ltd. INR 886 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 India Equity Institutional Research Automobiles RESULT UPDATE Minda Industries Ltd. INR 886 Profit boosted by margins ACCUMULATE In Q3FY16, Minda Industries

More information

The Ramco Cements. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research Robust performance; remains the best play on Southern region February 09, 2016 Kamlesh Bagmar kamleshbagmar@plindia.com +91 22 66322237 Ankit Shah ankitshah@plindia.com +91 22 66322244 Rating BUY Price

More information

MOSt Market Outlook 17th, August 2015

MOSt Market Outlook 17th, August 2015 Nifty Outlook News Nifty Immediate Heaviest Heaviest Support Call Put 8519 8300 8700 (4.9mn) 8200(6.6mn) Nifty took support in the expected zone of 8300-8350 and has witnessed a swift reversal from there.

More information

Techno Electric & Engineering Co Ltd

Techno Electric & Engineering Co Ltd ANTIQUE STOCK BROKING LIMITED 2 June 2016 1 Current Reco Previous Reco CMP Renjith Sivaram +91 22 4031 3414 renjith.sivaram@antiquelimited.com Dhirendra Tiwari +91 22 4031 3436 dhirendra.tiwari@antiquelimited.com

More information

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI $Com panyname$ Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) HOLD PI Industries Ltd. Custom synthesis

More information

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research

Bharat Electronics. Strong margins, improved inflows! Source: Company Data; PL Research Strong margins, improved inflows! January 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,228 Target Price Rs1,353

More information

Shriram Transport Finance Subsidiaries witness sharp increase in NPA

Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance Subsidiaries witness sharp increase in NPA Shriram Transport Finance s (STFC) standalone performance was broadly in-line with our expectation but grossly disappointed on asset

More information

Share gains with healthy margin uptick; Retain Buy

Share gains with healthy margin uptick; Retain Buy Colgate-Palmolive India Equity Research Consumers January 23, 2015 Result Update Emkay Your success is our success Share gains with healthy margin uptick; Retain Buy CMP Target Price Rs1,913 Rs1,940 (

More information

Techno Electric & Engineering Limited

Techno Electric & Engineering Limited Engineering & Capital Goods Event Update Techno Electric & Engineering Limited Buy Wind business spin off will lead to value unlocking. Institutional Research CMP (`) 404 Target (`) 504 Nifty: 8,224 Sensex:

More information

Union Bank of India SELL. Impairment ratio high maintain SELL. Results Review INDIA TP: INR 115.00 2.8% UNBK IN

Union Bank of India SELL. Impairment ratio high maintain SELL. Results Review INDIA TP: INR 115.00 2.8% UNBK IN 11 February 2016 SELL Impairment ratio high maintain SELL UNBK reported a dismal Q3FY16 as PAT dropped 74% YoY to Rs 785mn due to a sharp rise in provisions. Fresh impairments stood at Rs 46bn (Rs 32bn

More information

BUY ICICI BANK. Well managed P&L; balance sheet distressed. Target Price: Rs 285. Key drivers

BUY ICICI BANK. Well managed P&L; balance sheet distressed. Target Price: Rs 285. Key drivers 29 JAN 2016 Quarterly Update BUY Target Price: Rs 285 Well managed P&L; balance sheet distressed ICICI Bank reported a disappointing quarter with sharp deterioration in asset quality. The increase in NPLs

More information

Navin Fluorine International

Navin Fluorine International RESULTS REVIEW 2QFY16 29 OCT 2015 Navin Fluorine International INDUSTRY CHEMICALS CMP (as on 29 Oct 2015) Rs 1,579 Target Price Rs 1,800 Nifty 8,112 Sensex 26,838 KEY STOCK DATA Bloomberg NFIL IN No. of

More information

How To Grow In Kotak Bank

How To Grow In Kotak Bank Oct-14 Dec-14 Feb-15 Apr-15 Jun-15 Aug-15 Oct-15 Q2FY16 Result Update Getting back into action steadily October 30, 2015 Nitin Kumar nitinkumar@plindia.com +91-22-66322236 Pritesh Bumb priteshbumb@plindia.com

More information

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH Q2FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH SUPREME INDUSTRIES LTD Plastic Products BSE CODE:509930 NSE CODE: SUPREMEIND Bloomberg CODE: SIL IN SENSEX: 24,470 HOLD CMP Rs725

More information

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment $CompanyN ame$ Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 2QFY16 Result Review (Wholly owned subsidiary of Bank of Baroda) BUY Salzer Electronics Ltd. Steady

More information

State Bank of India SELL. Asset quality horror run to continue maintain SELL. Results Review INDIA TP: INR 150.00 2.8% SBIN IN

State Bank of India SELL. Asset quality horror run to continue maintain SELL. Results Review INDIA TP: INR 150.00 2.8% SBIN IN 11 February 2016 SELL Asset quality horror run to continue maintain SELL SBIN posted a disappointing Q3FY16 with PAT tumbling 61% QoQ to Rs 11.2bn on mounting provisions. Slippages climbed to Rs 206bn

More information

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value UK Daily Letter 1 K3 Business Technology Group KBT : AIM : 144p BUY Target: 215p Bob Liao, CFA 44.20.7050.6654 bliao@canaccordgenuity.com COMPANY STATISTICS: 52-week Range: 0.82-1.50 Avg. Daily Vol. (000s):

More information

HOLD. Mahindra & Mahindra Fin Secs. Earnings in line but asset quality concerns persist. Results Review INDIA TP: INR 270.00 12.

HOLD. Mahindra & Mahindra Fin Secs. Earnings in line but asset quality concerns persist. Results Review INDIA TP: INR 270.00 12. 21 October 2015 HOLD Earnings in line but asset quality concerns persist MMFS reported a soft Q2 marked by a 28% YoY decline in PAT to Rs 1.6bn, as provisions rose sharply and operating expenses shot up.

More information

HDFC Bank BUY. Strong, solid, steady. Results Review INDIA TP: INR 1,325.00 27.3% HDFCB IN

HDFC Bank BUY. Strong, solid, steady. Results Review INDIA TP: INR 1,325.00 27.3% HDFCB IN 25 January 2016 BUY Strong, solid, steady HDFCB delivered yet another strong quarter with reported Q3 PAT up 20% YoY to Rs 33.6bn and NII 24% YoY higher, in line with RCMLe. Loan growth was strong at 26%

More information

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights 05 FEB 2016 Quarterly Update BUY Target Price: Rs 344 Muted Q3; Brands & Retail story to unfold Arvind s Q3 consolidated revenue at Rs 21.6 bn (Rs 20.7 bn in Q3FY15) was marginally below our estimate of

More information

Aurobindo Pharma. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research Earnings in line; Strong guidance for FY17E maintained February 10, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs691 Target Price Rs943 Implied Upside 36.5% Sensex 23,759 Nifty

More information

Results impacted by subdued demand

Results impacted by subdued demand India Equity Research Agri Input & Chemicals January 25, 2016 Result Update Coromandel International Results impacted by subdued demand Emkay Your success is our success CMP Target Price Rs165 Rs225 (

More information

Larsen & Toubro. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research Order inflow surprise, challenges on profitability continues! January 29, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating BUY Price Rs1,102

More information

Simplex Infrastructures

Simplex Infrastructures 2QFY216 Result Update Infrastructure November 17, 215 Simplex Infrastructures Performance Highlights Quarterly highlights - Standalone Y/E March (` cr) 2QFY16 1QFY16 2QFY15 % chg (yoy) % chg (qoq) Net

More information

Shriram Transport Finance

Shriram Transport Finance Strong quarter amidst challenges February 01, 2016 Nitin Kumar nitinkumar@plindia.com +91 22 66322236 Pritesh Bumb priteshbumb@plindia.com +91 22 66322232 Rating BUY Price Rs844 Target Price Rs1,025 Implied

More information

Higher other income drive the quarter

Higher other income drive the quarter Gujarat State Petronet India Equity Research Oil & Gas February 4, 2016 Result Update Emkay Your success is our success Higher other income drive the quarter CMP Target Price Rs136 Rs163 ( ) Rating Upside

More information

CMP: INR788 TP: INR875 (+11%) Buy Halol facility receives warning letter

CMP: INR788 TP: INR875 (+11%) Buy Halol facility receives warning letter 21 December 2015 Update Sector: Healthcare Sun Pharma BSE SENSEX S&P CNX 25,519 7,762 Stock Info Bloomberg SUNP IN Equity Shares (m) 2,406.6 52-Week Range (INR) 1,201/706 1, 6, 12 Rel. Per (%) 6/0/3 M.Cap.

More information

Bank of Baroda SELL. Leaving legacy issues behind. Results Review INDIA TP: INR 115.00 1.1% BOB IN

Bank of Baroda SELL. Leaving legacy issues behind. Results Review INDIA TP: INR 115.00 1.1% BOB IN 13 February 2016 SELL Leaving legacy issues behind BOB reported a PBT loss of Rs 45bn for Q3FY16 as provisions spiked QoQ. However, tax write-backs of Rs 11bn helped the bank narrow the loss to Rs 33bn.

More information

Axis Bank BUY. More misses than hits. Results Review INDIA TP: INR 750.00 43.7% AXSB IN

Axis Bank BUY. More misses than hits. Results Review INDIA TP: INR 750.00 43.7% AXSB IN 27 October 2015 BUY More misses than hits AXSB s Q2 PAT grew 19% YoY to Rs 19.2bn on lower provisions and wellmanaged operating costs (+7% YoY). NIMs too improved 4bps QoQ to 3.85% on lower cost of funds

More information

Jubilant Life Sciences

Jubilant Life Sciences Radiopharma, Niacin continues to drive sales, margins October 30, 2015 Surajit Pal surajitpal@plindia.com +912266322259 Rating BUY Price Rs401 Target Price Rs578 Implied Upside 44.1% Sensex 26,838 Nifty

More information

CMP: INR300 TP: INR360(+20%) Buy

CMP: INR300 TP: INR360(+20%) Buy BSE SENSEX S&P CNX 24,492 7,438 Bloomberg HAVL IN Equity Shares (m) 624.6 M.Cap.(INRb)/(USDb) 187.4 / 2.8 52-Week Range (INR) 322 / 236 1, 6, 12 Rel. Per (%) 4/19/26 12M Avg Val (INR M) 435 Free float

More information

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights The case of missing sales growth Zydus Q3 net sales at Rs1.1 bn was up 3% on a like-to-like basis (Q3 15 had Rs 223 mn additional excise duty credit from prior periods), below our estimate of 6%. The company

More information

City Union Bank (CITUNI) 87

City Union Bank (CITUNI) 87 Result Update October 3, 215 Rating matrix Rating : Buy Target : 15 Target Period : 12 months Potential Upside : 2% What s Changed? Target Changed from 114 to 15 EPS FY16E Changed from 7.8 to 7.1 EPS FY17E

More information

SREI INFRASTRUCTURE FINANCE INR 62

SREI INFRASTRUCTURE FINANCE INR 62 ` India Equity Research Banking and Financial Services Result Update SREI INFRASTRUCTURE FINANCE INR 62 MTM forex loss hits earnings BUY June 15, 2009 Consolidated PAT at INR 40 mn; MTM forex loss hits

More information

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins

Emkay. Revenues traction improves; Retain BUY HSIL. Healthy revenue performance; miss on margins HSIL India Equity Research Others February 3, 2016 Result Update Emkay Your success is our success Revenues traction improves; Retain BUY CMP Target Price Rs271 Rs370 ( ) Rating Upside BUY ( ) 36.6 % Healthy

More information

Federal Bank (FEDBAN) 50

Federal Bank (FEDBAN) 50 Result Update Rating matrix Rating : Sell Target : 45 Target Period : 12 months Potential Upside : -10% What s Changed? Target Changed from 60 to 45 EPS Changed from 4.7 to 4.0 EPS Changed from 5.4 to

More information

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD

CMP: 1152.10 JUNE 2016 SWARAJ ENGINES LTD Index Details SWARAJ ENGINES LTD Result Update (PARENT BASIS): Q4 FY16 Stock Data Sector Auto Parts & Equipment BSE Code 500407 Face Value 10.00 52wk. High / Low (Rs.) 1207.90/762.00 Volume (2wk. Avg.)

More information

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers

HOLD. Q4 earnings beat but order backlog flat ABB. Target Price: Rs 1,213. Key drivers 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 1,213 Q4 earnings beat but order backlog flat s Q4CY15revenue at Rs24bnwasin line withour expectation of Rs24bn. EBITDA margin improved 290 bps YoYand

More information

Va Tech Wabag. Source: Company Data; PL Research

Va Tech Wabag. Source: Company Data; PL Research Weak execution, guidance hints a strong Q4FY16 February 08, 2016 Nishna Biyani nishnabiyani@plindia.com +91 22 66322239 Keyur Pandya keyurpandya@plindia.com +91 22 +91 22 66322247 Rating BUY Price Rs577

More information

Granules India Ltd. INR 113

Granules India Ltd. INR 113 India Equity Institutional Research Pharma RESULT UPDATE Granules India Ltd. INR 113 Misses expectation BUY Result highlights Net sales for the quarter grew by a moderate 8% YoY to INR 3,449mn below our

More information

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH Q3FY16 RESULT UPDATE GEOJIT BNP PARIBAS Research RETAIL EQUITY RESEARCH Exide Industries Ltd(EIL) Automobile Ancillaries BSE CODE: 500086 NSE CODE: EXIDEIND Bloomberg CODE: EXID IN SENSEX: 23,759 Accumulate

More information

India Equity Research Telecommunications September 2, 2015 Management Meet Update

India Equity Research Telecommunications September 2, 2015 Management Meet Update Bharti Infratel India Equity Research Telecommunications September 2, 2015 Management Meet Update Emkay Your success is our success Data demand to accelerate growth CMP Rs396 Target Price Rs505 ( ) Rating

More information

Pidilite Industries. Source: Company Data; PL Research

Pidilite Industries. Source: Company Data; PL Research Bountiful margin expansion in a tepid demand scenario February 03, 2016 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate

More information

Quant Picks United Breweries

Quant Picks United Breweries October 6, 2015 Quant Picks United Breweries Research Analyst Amit Gupta amit.gup@icicisecurities.com Raj Deepak Singh rajdeepak.singh@icicisecurities.com Azeem Ahmad azeem.ahmad@icicisecurities.com i

More information

Sanjay Jain (SanjayJain@MotilalOswal.com);Tel: +9122 3982 5412 Pavas Pethia (Pavas.Pethia@MotilalOswal.com); Tel: +9122 3982 5413 1

Sanjay Jain (SanjayJain@MotilalOswal.com);Tel: +9122 3982 5412 Pavas Pethia (Pavas.Pethia@MotilalOswal.com); Tel: +9122 3982 5413 1 BSE Sensex S&P CNX 19,407 5,916 Bloomberg JSP IN Equity Shares (m) 934.8 M.Cap. (INR b)/(usd b) 307.5/5.7 52-Week Range (INR) 515/313 1,6,12 Rel. Perf. (%) -11/-19/-44 Financials & Valuation (INR b) Y/E

More information

Tree House Education & Accessories

Tree House Education & Accessories 2QFY2016 Result Update Educational Services November 10, 2015 Tree House Education & Accessories Performance Highlights Y/E March (` cr) 2QFY16 2QFY15 % chg (qoq) 1QFY16 % chg (yoy) Net sales 57 50 15.1

More information

Bright Smart (1428 HK)

Bright Smart (1428 HK) Equity Research Financials Bright Smart (1428 ) Hold (initiation) Target price: $1.70 Local broker with high ROE; initiate at Hold Local broker with expansion ambition Bright Smart is a securities, commodities

More information

India Financials. Margin-cost based lending a breather for banks. Sector Update INDIA BANKING

India Financials. Margin-cost based lending a breather for banks. Sector Update INDIA BANKING Sector Update INDIA BANKING 17 December 2015 India Financials Margin-cost based lending a breather for banks To improve transmission of policy rates, the RBI has moved towards a new base rate formula,

More information

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights

HOLD HEXAWARE TECHNOLOGIES. Q4 lackluster; CY16 holds promise. Target Price: Rs 252. Q4earnings concall highlights 05 FEB 2016 Quarterly Update HOLD Target Price: Rs 252 Q4 lackluster; CY16 holds promise Hexaware s Q4CY15 performance was lower than our estimates. Revenue growth and margin were largely impacted due

More information

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16

BUY RSWM LTD SYNOPSIS. CMP 292.20 Target Price 336.00. SEPTEMBER 1 st 2015. Result Update(PARENT BASIS): Q1 FY16 BUY CMP 292.20 Target Price 336.00 RSWM LTD Result Update(PARENT BASIS): Q1 FY16 SEPTEMBER 1 st 2015 ISIN: INE611A01016 Index Details Stock Data Sector Textiles BSE Code 500350 Face Value 10.00 52wk. High

More information

ADANI PORTS AND SEZ To develop transshipment terminal at Mundra

ADANI PORTS AND SEZ To develop transshipment terminal at Mundra FLASH NOTE FLASH ADANI PORTS AND SEZ To develop transshipment terminal at Mundra India Equity Research Infrastructure - Ports COMPANYNAME Adani Ports and SEZ (Adani) has announced expansion of its existing

More information

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Result in line; Tepid guidance for Q4FY16 on weak EM, currency February 10, 2016 Surajit Pal surajitpal@plindia.com +912266322259 Rating Accumulate Price Rs2,960 Target Price Rs3,083 Implied Upside 4.2%

More information

Morning Buzz. Research Picks INDIA. India IT Services: Mixed quarter from Accenture. 21 December 2015

Morning Buzz. Research Picks INDIA. India IT Services: Mixed quarter from Accenture. 21 December 2015 Morning Buzz INDIA Research Picks 21 December 2015 India IT Services: Mixed quarter from Accenture This report has been prepared by Religare Capital Markets Limited or one of its affiliates. For analyst

More information

SREI Infrastructure Ltd.

SREI Infrastructure Ltd. Report Date 22nd Oct, 2010 Company Name SREI Infrastructure Ltd. Price / Recommendation CMP: - `121 Buy (Medium Risk Medium Return) Company Background SREI Infrastructure Finance Ltd started its operations

More information

Jindal Steel & Power. CMP: INR395 TP: INR382 Neutral

Jindal Steel & Power. CMP: INR395 TP: INR382 Neutral BSE SENSEX S&P CNX 16,839 5,100 Bloomberg JSP IN Equity Shares (m) 934.1 52-Week Range (INR) 663/390 1,6,12 Rel. Perf. (%) -7/-23/-29 M.Cap. (INR b) 369.0 M.Cap. (USD b) 6.7 Jindal Steel & Power CMP: INR395

More information

Outlook and valuation

Outlook and valuation February 9, 2016 Neutral Bajaj Auto Industry: Auto and Auto Components Industry View: Positive l Result Update Downgrade on export worries Q3 FY16 results came above our expectations despite exports worries

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 196.40 Target Price 225.00 STYLAM INDUSTRIES LIMITED Result Update (PARENT BASIS): Q2 FY16 DECEMBER 16 th. 2015 ISIN: INE239C01012 12 th h, 2013 Index Details Stock Data Sector Plastic Products

More information

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research. Sector Update Rating matrix Target price Company Old New CMP Potential Upside HEG 225 275 238 19% Graphite India 85 15 91 18% Target period 12-15 months Price performance (%) Return % 1M 3M 6M 12M HEG

More information

Bata India BUY. Favourable base shores up Q3, BUY. Results Review INDIA TP: INR 630.00 29.3% BATA IN

Bata India BUY. Favourable base shores up Q3, BUY. Results Review INDIA TP: INR 630.00 29.3% BATA IN Results Review 10 February 2016 BUY Favourable base shores up Q3, BUY BATA posted strong Q3FY16 results with net sales/ebitda/adj. PAT growth of 15%/30.4%/27.5% YoY as SSS grew by an estimated ~11-12%

More information

INR4b cash flow from stake sale in general insurance JV; Deleveraging

INR4b cash flow from stake sale in general insurance JV; Deleveraging 28 Mar 2013 Update Sector: Retail CMP: INR141 Under Review INR4b cash flow from stake sale in general insurance JV; Deleveraging largely done; Target price, Rating Under Review (PF IN, Mkt Cap USD 0.6b,

More information

Zee Entertainment BUY. Outlook steady; expect another strong quarter. Company Update INDIA TP: INR 465.00 9.4% Z IN

Zee Entertainment BUY. Outlook steady; expect another strong quarter. Company Update INDIA TP: INR 465.00 9.4% Z IN Company Update 6 January 2016 BUY Outlook steady; expect another strong quarter We recently interacted with ZEE s management and key highlights are: (1) Advertising revenue momentum, both domestic and

More information

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%) BUY CMP 170.30 Target Price 196.00 GEOMETRIC LTD Result Update (CONSOLIDATED): Q2 FY16 DECEMBER 17 th 2015 ISIN: INE797A01021 12 th h, 2013 Index Details Stock Data Sector IT Consulting & Software BSE

More information

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022

BUY. KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16. CMP 226.50 Target Price 260.00. JANUARY 9 th 2015 SYNOPSIS ISIN: INE164B01022 BUY CMP 226.50 Target Price 260.00 KELLTON TECH SOLUTIONS LTD Result Update (CONSOLIDATED): Q1 FY16 JANUARY 9 th 2015 ISIN: INE164B01022 Index Details Stock Data Sector IT Software Products BSE Code 519602

More information

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016 JSW Energy Ltd. Interest expenses dragged the bottom-line JSW Energy Ltd. (JSWEL) reported a mixed set of numbers for Q3 FY16 quarter. The company reported a consolidated total operating income of Rs.

More information

Investment Rationale

Investment Rationale TM PTC India Financial Services Ltd IPO Analysis 15th Mar. 2011 Recommendation : Subscribe Sector NBFC Bidding Details Price Band Rs 26 - Rs 28 Face value Rs 10 Bid Size 250 and in multiple thereof Issue

More information

Derivatives Weekly DERIVATIES DESK. Outlook: Outlook: Sell in May and Go Away! DOLAT CAPITAL. Brief Outlook :

Derivatives Weekly DERIVATIES DESK. Outlook: Outlook: Sell in May and Go Away! DOLAT CAPITAL. Brief Outlook : 18-Mar-16 21-Mar-16 22-Mar-16 23-Mar-16 28-Mar-16 29-Mar-16 30-Mar-16 31-Mar-16 1-Apr-16 4-Apr-16 5-Apr-16 6-Apr-16 7-Apr-16 8-Apr-16 11-Apr-16 12-Apr-16 13-Apr-16 18-Apr-16 20-Apr-16 21-Apr-16 22-Apr-16

More information

How To Understand The Performance Of An International Consulting Firm

How To Understand The Performance Of An International Consulting Firm Sector Update INDIA INFORMATION TECHNOLOGY 28 September 2015 India IT Services Accenture Strong Q4 but guidance disappoints Accenture s (ACN) Q4FY15 revenues of US$ 7.9bn (+12% YoY LC) beat expectations

More information

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold Equity Research Financials Cinda (111 HK) Hold (Initiation) Target price: HK$1.55 Facing intense competition from Chinese brokers in HK; initiate at Hold China Cinda s international business platform Cinda

More information

RamKrishna Forgings Ltd.

RamKrishna Forgings Ltd. January 3, 2014 RamKrishna Forgings Ltd. Poised for Growth CMP INR 81 Target INR 117.2 Coverage Follow Up BUY Key Share Data Face Value (INR) 10 Equity Capital (in INR Million) 211.0 Market Cap (in INR

More information